Global Psoriasis Treatment Market, By Drug Class (Corticosteroids, TNF Inhibitors, Interleukins, Others), Type (Plaque Psoriasis, Psoriatic Arthritis, Others), Route of Administration (Oral, Parenteral, Topical), Application (Topical Therapeutic Drugs, Systemic Therapeutic Drugs, Combinations), End User (Hospital Pharmacy, Clinics, Retail Pharmacies, Online Sales), Country (U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa) Industry Trends and Forecast to 2029.
Market Analysis and Insights Global Psoriasis Treatment Market
The psoriasis treatment market is expected to witness market growth at a rate of 7.85% in the forecast period of 2022 to 2029. Data Bridge Market Research report on psoriasis treatment market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The rise in the prevalence of chronic diseases globally is escalating the growth of psoriasis treatment market.
Psoriasis refers to a chronic inflammatory skin condition that is often connected with our systematic manifestation. This genetic condition that may or may not be present at birth, but it could also be triggered by genetic and environmental factors.
The rise in prevalence of psoriasis across the globe acts as one of the major factors driving the growth of psoriasis treatment market. The surge in the collaborations among manufacturers and increase in the awareness regarding treatment accelerate the market growth. The rise in disease burden and demand for psoriasis medicines in emerging economies, and surge in initiatives by government further influence the market. Additionally, development in technology, rise in population, increase in research and development for enhancement of treatment and surge in healthcare expenditure positively affect the psoriasis treatment market. Furthermore, increase in psoriasis research and pipeline drugs extend profitable opportunities to the market players in the forecast period of 2022 to 2029.
On the other hand, high cost associated with the drug development and most treatments is expected to obstruct the market growth. The delay in drug approvals is projected to challenge the psoriasis treatment market in the forecast period of 2022-2029.
This psoriasis treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info psoriasis treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Psoriasis Treatment Market Scope and Market Size
The psoriasis treatment market is segmented on the basis of drug class, type, route of administration, application and end user. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of drug class, the psoriasis treatment market is segmented into corticosteroids, TNF inhibitors, interleukins and others.
- On the basis of type, the psoriasis treatment market is segmented into plaque psoriasis, psoriatic arthritis and others.
- On the basis of route of administration, the psoriasis treatment market is segmented into oral, parenteral and topical.
- On the basis of application, the psoriasis treatment market is segmented into topical therapeutic drugs, systemic therapeutic drugs and combinations.
- On the basis of distribution channel, the psoriasis treatment market is segmented into hospital pharmacy, clinics, retail pharmacies and online sales.
Psoriasis Treatment Market Country Level Analysis
The psoriasis treatment market is analyzed and market size information is provided by country, drug class, treatment, end user and distribution channel as referenced above.
The countries covered in the global psoriasis treatment market report are U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).
North America dominates the psoriasis treatment market due to the presence of developed healthcare infrastructure within the region. Asia-Pacific is expected to witness high growth during the forecast period of 2022 to 2029 because of the large population in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
The psoriasis treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analyzed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Psoriasis Treatment Market Share Analysis
The psoriasis treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related psoriasis treatment market.
Some of the major players operating in the psoriasis treatment market report are Eli Lilly & Company, Pfizer Inc., Janssen Global Services LLC, Celgene Corporation, Takeda Pharmaceutical Company Limited, Novartis International AG, Amgen Inc., Biogen Inc., Abbvie Inc., AstraZeneca, Boeringer Ingelheim International GmbH, Biogen, Johnson & Johnson Services Inc., Merck & Co. Inc., Sun Pharmaceuticals Industries Ltd., Stiefel Laboratories, UCB S.A., LEO Pharma, Cipla Inc., Rowan Bioceuticals, Glenmark Pharmaceuticals, and Win-Medicare Pvt. Ltd., among others.
SKU-